# Protagonist Therapeutics, Inc: Form 8-K, filed Feb 21, 2025

- Company: [Protagonist Therapeutics, Inc](/companies/ptgx.md) (CIK 1377121)
- Form: 8-K
- Filed: 2025-02-21
- Accepted by EDGAR: Feb 21, 2025, 07:07 ET
- Period: 2025-02-21
- Accession: 0001104659-25-015897
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1377121/000110465925015897/tm257151d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1377121/000110465925015897/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1377121/000110465925015897/tm257151d1_8k.htm

Filed Feb 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-015897. Last ingested by Listed: Nov 6, 2026, 12:26 ET. No prices; not investment advice.